[Contraconception in women with systemic lupus erythematosus]

Rev Invest Clin. 2009 Mar-Apr;61(2):150-9; discussion 159-60.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Clinical Conference

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antiphospholipid Syndrome / complications
  • Contraception / methods*
  • Contraception, Barrier
  • Contraceptives, Oral, Combined / adverse effects
  • Contraceptives, Oral, Combined / pharmacology
  • Contraceptives, Oral, Hormonal / adverse effects
  • Contraceptives, Oral, Hormonal / pharmacology
  • Contraindications
  • Female
  • Gonadal Steroid Hormones / adverse effects
  • Gonadal Steroid Hormones / metabolism
  • Humans
  • Intrauterine Devices, Copper
  • Intrauterine Devices, Medicated / adverse effects
  • Levonorgestrel / adverse effects
  • Lupus Erythematosus, Systemic* / complications
  • Lupus Erythematosus, Systemic* / drug therapy
  • Lupus Erythematosus, Systemic* / metabolism
  • Practice Guidelines as Topic
  • Pregnancy
  • Pregnancy, High-Risk
  • Progestins / administration & dosage
  • Progestins / adverse effects
  • Progestins / pharmacology
  • Thrombophilia / chemically induced
  • Thrombophilia / etiology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Contraceptives, Oral, Combined
  • Contraceptives, Oral, Hormonal
  • Gonadal Steroid Hormones
  • Progestins
  • Levonorgestrel
  • belimumab